Market-Moving Exclusives - Spark Newswire

10 minute read

EXCLUSIVE: Babylon Q1 Loss $91.4M vs Loss $10.8M In Same Qtr. Last Year, Adj. EBITDA Loss $72.2M vs Loss $4.6M Year Over Year, Sales $266.4M vs $71.3M YoY

May 12, 5:50 AM

PALO ALTO, CALIFORNIA and LONDON, UK – May 12, 2022 (BUSINESS WIRE) – Babylon Holdings Limited (NYSE:BBLN) (“Babylon” or “the Company”), one of the world’s fastest growing

BBLN

2 minute read

EXCLUSIVE: How Are Cannabis Companies Navigating The Current Capital Dry Spell?

By Natan Ponieman

April 20, 8:47 PM

Raising capital in the current market is proving to be increasingly challenging for cannabis companies today.

FLGC

2 minute read

EXCLUSIVE: AgriFORCE Reports Notice Of Allowance From Canadian Intellectual Property Office For Its Patent Application For ‘Structures For Growing Plants’

By Benzinga Newsdesk

April 20, 8:20 AM

ANCOUVER, B.C. – April 20th, 2022 – AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ:AGRI, AGRIW)), an intellectual property (IP)- focused AgTech company dedicated to advancing sustainable

AGRI

2 minute read

EXCLUSIVE: Expion360 Completes UL 1973 Compliance On Its 60-120Ah Batteries

By Benzinga Newsdesk

April 20, 8:03 AM

REDMOND, OR / ACCESSWIRE / April 20, 2022 / Expion360, Inc. (NASDAQ:XPON), an industry leader for lithium batteries and accessories for recreational vehicles, outdoor, marine, residential, and industrial,

XPON

2 minute read

EXCLUSIVE: Grove’s Amazon Brand Aggregator, Upexi, Acquires Controlling Interest In Cygnet Online; Terms Not Disclosed

By Benzinga Newsdesk

April 20, 8:00 AM

HENDERSON, NV / April 20, 2022 / Grove, Inc. (NASDAQ:GRVI) a global innovator in health, and wellness, announced that Upexi, its wholly-owned Amazon brand aggregator has acquired a controlling interest in Cygnet Online

GRVI

2 minute read

Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury

By Nicolas Jose Rodriguez

April 20, 7:59 AM

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway.

WSNAF

5 minute read

EXCLUSIVE: Safe-T Group Sees Q1 Sales ~$4M Vs. $3.23M Est.

By Benzinga Newsdesk

April 18, 8:20 AM

HERZLIYA, Israel, April 18, 2022 - Safe-T® Group Ltd. (Nasdaq, TASE: SFET) (“Safe-T” or the “Company”), a global provider of cybersecurity and privacy solutions to consumers and enterprises, today provided

SFET

2 minute read

EXCLUSIVE: Xometry Says Its Instant Pricing App Now Available In The Onshape Store

By Benzinga Newsdesk

April 14, 6:00 AM

ROCKVILLE, Md. – April 14, 2022 – Xometry today announced the immediate availability of the Xometry Instant Pricing app for PTC’s Onshape®, the cloud-native CAD product development platform

XMTR

3 minute read

EXCLUSIVE: Longeveron Reports Cooperative Research, Development Deal With US Dept. Of Veterans Affairs For Addition Of A Miami Veterans Affairs Clinical Site To Its Ongoing Phase 2 Alzheimer’s Trial

By Benzinga Newsdesk

April 13, 7:30 AM

Miami, Florida – April 13, 2022 - Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related

LGVN